DaVita Inc CEO Javier Rodriguez Sells 75,000 Shares
DaVita Inc (NYSE:DVA), a company specializing in kidney care and dialysis services, has reported an insider sell according to a recent SEC filing. CEO Javier Rodriguez sold 75,000 shares of the company on February 27, 2024.Javier Rodriguez has been actively trading shares over the past year, with a total of 91,916 shares sold and no shares purchased. This latest transaction continues the trend observed in the insider transaction history for DaVita Inc, which has seen 12 insider sells and no insider buys over the past year.
On the day of the insider's recent sell, shares of DaVita Inc were trading at $126.18, giving the company a market cap of $11.09 billion. The price-earnings ratio of the company stands at 17.16, which is lower than the industry median of 26.38 and also below the company's historical median price-earnings ratio.DaVita Inc's stock valuation, when compared to the GuruFocus Value (GF Value) of $109.61, indicates a price-to-GF-Value ratio of 1.15. This suggests that the stock is modestly overvalued.
The GF Value is determined by considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's past returns and growth, and future business performance estimates from Morningstar analysts.For more detailed information on the insider's trading activities and the company's financials, readers can refer to the SEC Filing.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
